Dalfopristin

CHEMBL1200937 Phase 4 Aprovado Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
690.8 g/mol
LogP
2.2
Phase
4

An antibiotic that is part of the streptogramin class, used in combination with quinupristin to treat serious infections caused by certain resistant bacteria. It works by interfering with protein synthesis in bacteria.

Peso Molecular

690,8000 g/mol

LogP

2,20

TPSA

185,00 Ų

Regra dos 5 de Lipinski

Reprovado

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Estrutura 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CCN(CC)CCS(=O)(=O)[C@@H]1CCN2C(=O)c3coc(n3)CC(=O)C[C@H](O)/C=C(C)/C=C/CNC(=O)/C=C/[C@@H](C)[C@@H](C(C)C)OC(=O)[C@@H]12

InChI

InChI=1S/C34H50N4O9S/c1-7-37(8-2)16-17-48(44,45)28-13-15-38-31(28)34(43)47-32(22(3)4)24(6)11-12-29(41)35-14-9-10-23(5)18-25(39)19-26(40)20-30-36-27(21-46-30)33(38)42/h9-12,18,21-22,24-25,28,31-32,39H,7-8,13-17,19-20H2,1-6H3,(H,35,41)/b10-9+,12-11+,23-18+/t24-,25-,28-,31-,32-/m1/s1

Molecular Formula

C34H50N4O9S

HBD / HBA

2 / 11

Ligações Rotacionáveis

7

Átomos Pesados

48

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Perguntas frequentes

An antibiotic that is part of the streptogramin class, used in combination with quinupristin to treat serious infections caused by certain resistant bacteria. It works by interfering with protein synthesis in bacteria.

Yes, Dalfopristin is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1200937. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 6323289. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Aviso Médico

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.